Zimbabwe has declined a major American health deal worth 367 million US dollars (£272m) spanning five years due to Washington's request for sensitive biological samples.
The decision became public after a government memo from December was leaked, which showed President Emmerson Mnangagwa believed the arrangement was "skewed".
An official spokesperson later explained that the US was requesting health data for scientific study and profit while was unwilling to guarantee the benefits from any future vaccines.
"We are forced to start the difficult and regrettable process of scaling back our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the US had donated over $1.9bn as health assistance to Zimbabwe over the last twenty years.
A physicians' group in Zimbabwe has called for continued talks to secure a deal agreeable to both sides so the nation's critical HIV treatment initiative can proceed.
Broader Context
This rejection follows a comparable situation in neighbouring Kenya, where a high court suspended a related deal with the US following legal challenges were raised about the security of Kenyans' health data.
After resuming office last year, US President Donald Trump has reduced foreign aid and shut down the US Agency for International Development (USAID).
USAID had administered aid for the American government, but Trump argued its expenditure was "wasteful" and his government was pursuing direct bilateral agreements to boost transparency and responsibility.
According to statements, 16 nations in Africa have to date signed these new agreements, representing over $18.3bn in new funding.
Specifics of the Rejected Deal
The money for Zimbabwe would have funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this collaboration might have yielded immense advantages for Zimbabwean communities, particularly the 1.2 million presently on antiretroviral therapy via US-supported programmes," Tremont commented.
However, official spokesman Nick Mangwana maintained the proposed deal was "unequal".
"The proposal required Zimbabwe to surrender its genetic material and health information over an extended period, with no corresponding assurance of benefiting from any scientific breakthroughs – such as new medicines or tests – that could be developed from that provided information," he stated.
"Put simply, our nation would supply the raw materials for medical research with no assurance that the end products would be available to our people should a future health crisis arise."
National Interest and Global Health
Mangwana further noted that the US's withdrawal from the World Health Organization (WHO) and its push of one-on-one deals were undermining frameworks already established through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.
"This mechanism is designed to ensure that when a nation contributes its samples, the resulting advantages – such as medicines and cures – are distributed fairly, not monopolised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "must not be interpreted as hostility towards the US," he added.
"We are open to continued dialogue with our US partners on how future co-operation could be structured in a manner that honours the independence and interests of both nations."
Medical Community Reaction
Medical experts expressed it acknowledged the government's concerns, but suggested that talks need to persist considering much of the country's Aids initiatives depended on foreign aid.
"In cases where specific concerns exist, such as those relating to information security or implementation frameworks, these can frequently be addressed via detailed discussion and mutually agreed protections," the group added.
The situation emphasises the ongoing debate between accepting vital foreign assistance and safeguarding national sovereignty in an ever more interconnected world.